Why is Indo US Bio-Tech falling/rising?

As of 29-Jul, Indo US Bio-Tech Ltd's stock price is currently at Rs 161.40, reflecting a decrease of Rs 1.15 or 0.71%. The stock has been on a downward trend, having lost 5% over the last two days, and it opened today with a gain of 3.05%, reaching an intraday high of Rs 167.5 before falling to a low of Rs 155.6. Over the past week, the stock has declined by 13.64%, while it has shown a modest increase of 5.80% over the past month. Despite a strong performance in the long term with a 3-year return of 257.67% and a 5-year return of 720.50%, the stock has underperformed recently, with a year-to-date decline of 48.76%. The company's strong management efficiency, low debt to EBITDA ratio, and consistent profit growth are positive factors; however, its high valuation and significant underperformance compared to the market over the past year raise concerns. Broader Market Context: In the context of the broader market, Indo US Bio-Tech's recent performance contrasts sharply with the Sensex, which has only fallen by 1.03% over the past week and has gained 4.09% year-to-date. The stock's significant decline over the past year, at -28.27%, indicates a stark underperformance compared to the market's slight negative return of -2.26%. This disparity suggests that while the company has shown strong operational metrics, investor sentiment may be negatively impacted by its high valuation and recent price movements, leading to a cautious outlook among investors.